TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11744565

Group type: EXPERIMENTAL
Intervention: Postal questionnaire
Number of subjects: 32990

Group type: EXPERIMENTAL
Intervention: Interview by lay interviewer
Number of subjects: 32990

Group type: EXPERIMENTAL
Intervention: Interview by nurse
Number of subjects: 32990

Group type: COMPARATOR
Intervention: Control (interview methods combined)
Number of subjects: 32990
Study: 9017772

Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftibuten (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (500 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefaclor (500 mg)
Number of subjects: 0
Study: 8318323

Group type: EXPERIMENTAL
Intervention: Local anaesthetic infiltration prior to cannulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: No local anaesthetic infiltration
Number of subjects: 40
Study: 3531311

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.i.d. plus aspirin 650 mg q.i.d.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo b.i.d. plus aspirin 650 mg q.i.d.
Number of subjects: 40
Study: 29572600

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study: 28481230

Group type: EXPERIMENTAL
Intervention: 50 g isomaltulose in 400 mL of water
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50 g isomaltulose in 400 mL of green tea
Number of subjects: 15

Group type: COMPARATOR
Intervention: 50 g sucrose in 400 mL of water
Number of subjects: 15

Group type: COMPARATOR
Intervention: Green tea with sucrose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Green tea with isomaltulose
Number of subjects: 15
Study: 26552022

Group type: EXPERIMENTAL
Intervention: Bevacizumab-based chemotherapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 86
Study: 23855318

Group type: EXPERIMENTAL
Intervention: Phone + Face-to-Face
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Face-to-Face Only
Number of subjects: 58

Group type: COMPARATOR
Intervention: Both programs
Number of subjects: 58
Study: 20597629

Group type: EXPERIMENTAL
Intervention: Client-centred self-care intervention (CCSCI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ordinary training (Control)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (IG and CG)
Number of subjects: 40
Study: 18454042

Group type: EXPERIMENTAL
Intervention: Wetting alarm diaper training (WAD-T)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Timed potty training (TP-T)
Number of subjects: 39
Study: 16571280

Group type: EXPERIMENTAL
Intervention: Astragalus Injection (AI) 20 ml in 250 ml of 5% glucose solution given through intravenous dripping
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 63
Study: 14577838

Group type: COMPARATOR
Intervention: Dawn simulator devices used for two weeks at a time during an eight-week study period.
Number of subjects: 100
Study: 12775739

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Imatinib (after crossover)
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Interferon alfa plus low-dose cytarabine (IFN+LDAC)
Number of subjects: 1049
Study: 10367553

Group type: COMPARATOR
Intervention: MDMA (1.7 mg/kg, orally) in humans
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDMA (1.7, 5.4, and 17.0 mg/kg) in rats
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in humans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in rats
Number of subjects: 0
Study: 8904739

Group type: EXPERIMENTAL
Intervention: Befloxatone 2.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Befloxatone 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Befloxatone 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1653145

Group type: EXPERIMENTAL
Intervention: Controlled-release tablets (30 mg every 12 h)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Solution (15 mg every 6 h)
Number of subjects: 11
Study: 6363696

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30064268

Group type: EXPERIMENTAL
Intervention: Combined intervention of physical exercise and cognitive training (n=55; 50-minute session + 60-minute session)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Physical exercise (n=56; 50-minute session)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Cognitive training (n=57; 60-minute session)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (n=57; 45-minute session)
Number of subjects: 225
Study: 30368448

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (BF) Spiromax
Number of subjects: 1476

Group type: COMPARATOR
Intervention: BF Turbuhaler
Number of subjects: 1476
Study: 27434297

Group type: EXPERIMENTAL
Intervention: 150 mg Nilotinib
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 300 mg Nilotinib
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nilotinib (both doses)
Number of subjects: 12
Study: 24579935

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 (1 × 10^8 CFU for 5 days)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 127
Study: 23319889

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 90
Study: 20965978

Group type: EXPERIMENTAL
Intervention: High-sensitivity C reactive protein (hsCRP)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Pentraxin-3 (PTX3)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Recurrent AF
Number of subjects: 382
Study: 17690742

Group type: EXPERIMENTAL
Intervention: FEXOFENADINE 180 mg Film Tablet (Drogsan A.S., Ankara, Turkey)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Telfast 180 mg Tablet (Aventis Pharma, Frankfurt am Main, Germany)
Number of subjects: 25
Study: 15361515

Group type: EXPERIMENTAL
Intervention: RMSdi measured during steady-state ventilation at seven levels of inspired O2 fraction (Fi(CO(2))) from 0 to 0.08
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: RMSdi%max-Pco(2) relationships
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: RMSdi/ECG(R)-Pco(2) relationships
Number of subjects: 7
Study: 11916788

Group type: EXPERIMENTAL
Intervention: Korean hand acupressure (performed 30 min before anesthesia using acupressure seeds on K-K9 for at least 24 h)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (no active acupressure)
Number of subjects: 80
Study: 9537342

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 104
Study: 7702022

Group type: EXPERIMENTAL
Intervention: White wine with low concentration of polyphenols
Number of subjects: 33

Group type: COMPARATOR
Intervention: Red wine with high concentration of polyphenols
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Red wine with reduced alcohol content
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Red wine with reduced alcohol content consumed with food (small bread roll)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: White wine with reduced alcohol content
Number of subjects: 33
Study: 2676312

Group type: EXPERIMENTAL
Intervention: Breast-fed every 4 hours (62 infants)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Breast-fed every 3 hours (90 infants)
Number of subjects: 152
Study: 40893

Group type: EXPERIMENTAL
Intervention: Biphasic norgestrel/ethinyl estradiol regimen
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Triphasic norgestrel/ethinyl estradiol regimen
Number of subjects: 458

Group type: COMPARATOR
Intervention: Fixed dose norgestrel/ethinyl estradiol preparation (300 mcg norgestrel and 30 mcg ee)
Number of subjects: 458
Study: 31168676

Group type: EXPERIMENTAL
Intervention: 3D printed scaffolds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naphthalene scaffolds (traditional processing)
Number of subjects: 0
Study: 29659183

Group type: EXPERIMENTAL
Intervention: 0.5 mg intravitreal aflibercept (IVT‐AFL) injection every 4 weeks (0.5q4)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: 2 mg IVT‐AFL every 4 weeks (2q4)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: 2 mg IVT‐AFL every 8 weeks (2q8)
Number of subjects: 1815

Group type: COMPARATOR
Intervention: 0.5 mg intravitreal ranibizumab every 4 weeks (0.5q4)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: All treatments (IVT‐AFL and ranibizumab)
Number of subjects: 1815
Study: 29126422

Group type: EXPERIMENTAL
Intervention: CHMI-a and CHMI-b (exposure to infected mosquitoes)
Number of subjects: 39
Study: 25298028

Group type: EXPERIMENTAL
Intervention: Cytotoxic activity of MRSA isolates
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Low cytotoxicity MRSA isolates
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Clone with low cytotoxic activity
Number of subjects: 386
Study: 24204066

Group type: EXPERIMENTAL
Intervention: Insomnia Severity Index (ISI)
Number of subjects: 410
Study: 21767415

Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Mefloquine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both SP and Mefloquine
Number of subjects: 93
Study: 18091548

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin G 10% (ivIgG) - 6 mL [600 mg]/kg on day 1 and 3 mL [300 mg]/kg on day 2
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo (albumin 0.1%) - 6 mL [6 mg]/kg on day 1 and 3 mL [3 mg]/kg on day 2
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin G 10% (ivIgG)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo (albumin 0.1%)
Number of subjects: 244
Study: 16935946

Group type: EXPERIMENTAL
Intervention: Telephone administered cognitive behaviour therapy (CBT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Face to face cognitive behaviour therapy (CBT)
Number of subjects: 72
Study: 12971668

Group type: EXPERIMENTAL
Intervention: Family-based directly observed treatment (FDOT)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Standard supervised but non-observed therapy (ST)
Number of subjects: 173
Study: 11425414

Group type: EXPERIMENTAL
Intervention: Smoking cessation (abstinence)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Smoking (continuation)
Number of subjects: 100
Study: 9237141

Group type: EXPERIMENTAL
Intervention: Partial denture with distal occlusal rests and cast circumferential clasps
Number of subjects: 118

Group type: COMPARATOR
Intervention: Partial denture with mesial rests and I-bar cast clasps
Number of subjects: 118
Study: 7525999

Group type: EXPERIMENTAL
Intervention: Aneuploid DNA profiles in interstitial cystitis patients (n=14)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Aneuploid DNA profiles in control patients (n=11)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: DNA tetraploid population in interstitial cystitis patients (n=14)
Number of subjects: 14

Group type: COMPARATOR
Intervention: DNA tetraploid population in control patients (n=11)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Binucleated cytokeratin positive cells in interstitial cystitis patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Binucleated cytokeratin positive cells in control patients
Number of subjects: 14
Study: 3302841

Group type: EXPERIMENTAL
Intervention: Trazodone hydrochloride 150 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2190839

Group type: EXPERIMENTAL
Intervention: 30 mg tamoxifen/day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 30 mg tamoxifen/day and 600 IU kallikrein/day
Number of subjects: 67
Study: 4494855

Group type: EXPERIMENTAL
Intervention: Description of only 2 of the sensations the subjects could expect to experience
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Description of all the typical sensations experienced
Number of subjects: 52

Group type: COMPARATOR
Intervention: Description of sensations unlikely to occur with ischemic pain
Number of subjects: 52

Group type: COMPARATOR
Intervention: Description of the procedure void of sensations
Number of subjects: 52
Study: 31520695

Group type: EXPERIMENTAL
Intervention: Systemic therapy followed by resectability assessment by the Expert Panel
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Curative procedures performed on patients with resectable CRLM
Number of subjects: 183
Study: 28024275

Group type: EXPERIMENTAL
Intervention: Stress induction during memory reactivation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions (no reactivation, no stress, or both)
Number of subjects: 0
Study: 25896460

Group type: EXPERIMENTAL
Intervention: Choroidal thickness measurements at various locations (fovea, N750, N1500, N2250, T750, T1500, T2250)
Number of subjects: 294
Study: 23443875

Group type: COMPARATOR
Intervention: Oral paracetamol (1,000 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intracutaneous sterile water injection
Number of subjects: 45
Study: 22436512

Group type: EXPERIMENTAL
Intervention: Cortical thickness in left ventromedial and right dorsolateral prefrontal cortices
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cortical thickness in left inferior frontal, left cingulate, and right dorsomedial prefrontal cortices
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: White matter volume in right frontal white matter
Number of subjects: 105
Study: 19849857

Group type: EXPERIMENTAL
Intervention: Culturally-appropriate hypertension education (three sessions, culturally-specific materials, targeted lifestyle support)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard hypertension education (usual care)
Number of subjects: 148
Study: 17823436

Group type: EXPERIMENTAL
Intervention: Low-glycemic-index (LGI) diet
Number of subjects: 203

Group type: COMPARATOR
Intervention: High-glycemic-index (HGI) diet
Number of subjects: 203
Study: 14679399

Group type: EXPERIMENTAL
Intervention: 3MU of IFN-beta twice a day at intervals of 5 and 19 h (Group A)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3MU of IFN-beta twice a day at intervals of 10 and 14 h (Group B)
Number of subjects: 9

Group type: COMPARATOR
Intervention: 6MU of IFN-alpha once a day with ribavirin (Group C)
Number of subjects: 9
Study: 10655829

Group type: EXPERIMENTAL
Intervention: Sequential single pumping regimen
Number of subjects: 39

Group type: COMPARATOR
Intervention: Simultaneous double pumping regimen
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Previous breastfeeding experience
Number of subjects: 39

Group type: COMPARATOR
Intervention: No previous breastfeeding experience
Number of subjects: 39
Study: 8909755

Group type: EXPERIMENTAL
Intervention: Silicone net dressing (Mepitel)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Paraffin gauze dressing
Number of subjects: 38
Study: 2069370

Group type: EXPERIMENTAL
Intervention: Netilmicin (6 mg/kg/day) given once daily (qd)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Netilmicin (6 mg/kg/day) given thrice daily (tid)
Number of subjects: 60
Study: 6347782

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg three times a day for 4-6 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 14
Study: 31041545

Group type: EXPERIMENTAL
Intervention: Continue thiopurines (Con) group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Discontinue thiopurines (Dis) group
Number of subjects: 50
Study: 28768217

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 333

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 333
Study: 25516113

Group type: EXPERIMENTAL
Intervention: Mud-bath therapy (MBT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (usual treatment)
Number of subjects: 103
Study: 23403431

Group type: EXPERIMENTAL
Intervention: GSK1322322 (100, 200, 400, 800, 1500 mg; 800 mg with high-fat meal)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: GSK1322322 (800 mg with high-fat meal)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: GSK1322322
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 21592898

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 40
Study: 19754931

Group type: EXPERIMENTAL
Intervention: Proprietary melon juice concentrate (Extramel) 10 mg corresponding to 140 IU SOD per capsule, taken once daily for 4 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo, taken once daily for 4 weeks
Number of subjects: 70
Study: 16775183

Group type: EXPERIMENTAL
Intervention: Photobook intervention provided immediately (n = 49)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Photobook intervention provided 4 months after initial intervention delivery (n = 51)
Number of subjects: 100
Study: 15022020

Group type: EXPERIMENTAL
Intervention: Homemade fishing line suture
Number of subjects: 220

Group type: COMPARATOR
Intervention: Commercial nylon thread (Ethilon)
Number of subjects: 220
Study: 10659979

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (900 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9107002

Group type: EXPERIMENTAL
Intervention: High threat exposure with an affiliate facing the same situation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: High threat exposure with an affiliate facing a different situation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Low threat exposure with an affiliate facing the same situation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Low threat exposure with an affiliate facing a different situation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Behavioral mimicry (facial expressions)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Emotional contagion (self-reported anxiety)
Number of subjects: 2
Study: 1389351

Group type: EXPERIMENTAL
Intervention: Rembrandt Lightening Gel and Whitening Toothpaste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rembrandt Toothpaste alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bleaching system
Number of subjects: 0
Study: 3905327

Group type: EXPERIMENTAL
Intervention: Iso Mack Retard 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Two development products
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isoket Retard 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sustained release preparations
Number of subjects: 8

Group type: COMPARATOR
Intervention: Isoket retard 20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: IS‐5‐MN non-retard
Number of subjects: 8
Study: 31481370

Group type: EXPERIMENTAL
Intervention: Youth Aware of Mental Health (YAM)
Number of subjects: 8600

Group type: EXPERIMENTAL
Intervention: Mental Health and High School Curriculum Guide (The Guide)
Number of subjects: 8600

Group type: COMPARATOR
Intervention: Usual Provision
Number of subjects: 8600

Group type: EXPERIMENTAL
Intervention: YAM and The Guide
Number of subjects: 8600
Study: 29670335

Group type: EXPERIMENTAL
Intervention: Fimasartan (120 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Co-administration of fimasartan and rosuvastatin
Number of subjects: 36
Study: 28778920

Group type: EXPERIMENTAL
Intervention: Mildly impaired physical and mental health (22% of patients)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Moderately impaired physical and mental health (39%)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Severely impaired physical health with moderately impaired mental health (15%)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Severely impaired physical and mental health (24%)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Classification rule adequacy
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Female Latino smokers
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Male non-Latino non-smokers
Number of subjects: 645
Study: 25171881

Group type: EXPERIMENTAL
Intervention: Magnetic sphincter augmentation (MSAD)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Laparoscopic fundoplication (LF)
Number of subjects: 249
Study: 23723119

Group type: EXPERIMENTAL
Intervention: Designing a patient education poster
Number of subjects: 329

Group type: COMPARATOR
Intervention: Case‐oriented education (control group)
Number of subjects: 329
Study: 21192940

Group type: EXPERIMENTAL
Intervention: Oral progesterone (150 mg BID) during the follicular phase
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal follicular phase
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal luteal phase
Number of subjects: 10
Study: 18492838

Group type: EXPERIMENTAL
Intervention: Combination of phytosterols and (n‐3) LCPUFA
Number of subjects: 60

Group type: COMPARATOR
Intervention: (n‐3) LCPUFA alone
Number of subjects: 60
Study: 16538000

Group type: EXPERIMENTAL
Intervention: Glimepiride (GP group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Glibenclamide (GB group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Insulin therapy (INS group)
Number of subjects: 34
Study: 14618042

Group type: EXPERIMENTAL
Intervention: Intravenous esmolol for 24 hours post-CABG followed by oral beta-blocker
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard oral beta-blocker treatment
Number of subjects: 50
Study: 11012562

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9268782

Group type: EXPERIMENTAL
Intervention: Computer Assisted Instruction (CAI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Interactive Lecture
Number of subjects: 10
Study: 8325278

Group type: EXPERIMENTAL
Intervention: Oral flumazenil (30 or 100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam (15 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3791364

Group type: EXPERIMENTAL
Intervention: tolciclate solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo solution
Number of subjects: 40
Study: 28834822

Group type: EXPERIMENTAL
Intervention: MIPO
Number of subjects: 58

Group type: COMPARATOR
Intervention: Minimal ORIF
Number of subjects: 58